{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T15:37:14Z","timestamp":1742398634616},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Sichuan Natural Science Foundation","doi-asserted-by":"crossref","award":["2022NSFSC0805"],"award-info":[{"award-number":["2022NSFSC0805"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2022M720102"],"award-info":[{"award-number":["2022M720102"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Portal hypertension (PHT) has been proven to be closely related to the development of hepatocellular carcinoma (HCC). Whether PHT before liver transplantation (LT) will affect the recurrence of HCC is not clear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>110 patients with depressurization of the portal vein (DPV) operations (Transjugular Intrahepatic Portosystemic Shunt\u2014TIPS, surgical portosystemic shunt or\/and splenectomy) before LT from a HCC LT cohort, matched with 330 preoperative non-DPV patients; this constituted a nested case-control study. Subgroup analysis was based on the order of DPV before or after the occurrence of HCC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The incidence of acute kidney injury and intra-abdominal bleeding after LT in the DPV group was significantly higher than that in non-DPV group. The 5-year survival rates in the DPV and non-DPV group were 83.4% and 82.7% respectively (<jats:italic>P<\/jats:italic>\u2009=\u20090.930). In subgroup analysis, patients in the DPV prior to HCC subgroup may have a lower recurrence rate (4.7% vs.16.8%, <jats:italic>P<\/jats:italic>\u2009=\u20090.045) and a higher tumor free survival rate (88.9% vs.74.4%, <jats:italic>P<\/jats:italic>\u2009=\u20090.044) after LT under the up-to-date TNMI\u2013II stage, while in TNM III stage, there was no difference for DPV prior to HCC subgroup compared with the DPV after HCC subgroup or the non-DPV group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Compared with DPV after HCC, DPV treatment before HCC can reduce the recurrence rate of HCC after early transplantation (TNM I-II). DPV before LT can reduce the recurrence of early HCC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-12322-6","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T15:02:01Z","timestamp":1714748521000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Does depressurization of the portal vein before liver transplantation affect the recurrence of HCC? A nested case-control study"],"prefix":"10.1186","volume":"24","author":[{"given":"Guo","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shifeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingsheng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingxiang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,3]]},"reference":[{"issue":"6","key":"12322_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/TP.0000000000003174","volume":"104","author":"N Mehta","year":"2020","unstructured":"Mehta N, Bhangui P, Yao FY, Mazzaferro V, Toso C, Akamatsu N, et al. Liver transplantation for hepatocellular carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference. Transplantation. 2020;104(6):1136\u201342.","journal-title":"Transplantation"},{"issue":"39","key":"12322_CR2","doi-asserted-by":"publisher","first-page":"11185","DOI":"10.3748\/wjg.v21.i39.11185","volume":"21","author":"N de\u2019Angelis","year":"2015","unstructured":"de\u2019Angelis N, Landi F, Carra MC, Azoulay D. Managements of recurrent hepatocellular carcinoma after liver transplantation: a systematic review. World J Gastroenterol. 2015;21(39):11185\u201398.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"12322_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1001\/jamasurg.2019.0407","volume":"154","author":"EW Lee","year":"2019","unstructured":"Lee EW, Shahrouki P, Alanis L, Ding P, Kee ST. Management options for gastric variceal hemorrhage. JAMA Surg. 2019;154(6):540\u20138.","journal-title":"JAMA Surg"},{"issue":"5","key":"12322_CR4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1055\/s-0038-1672200","volume":"39","author":"K Rajwani","year":"2018","unstructured":"Rajwani K, Fortune BE, Brown RS, Jr. Critical care management of gastrointestinal bleeding and ascites in liver failure. Semin Respir Crit Care Med. 2018;39(5):566\u201377.","journal-title":"Semin Respir Crit Care Med"},{"issue":"7","key":"12322_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00535-021-01788-x","volume":"56","author":"H Yoshiji","year":"2021","unstructured":"Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2020. J Gastroenterol. 2021;56(7):593\u2013619.","journal-title":"J Gastroenterol"},{"issue":"5","key":"12322_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/1756283X14538688","volume":"7","author":"I Cremers","year":"2014","unstructured":"Cremers I, Ribeiro S. Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis. Th Adv Gastroenterol. 2014;7(5):206\u201316.","journal-title":"Th Adv Gastroenterol"},{"issue":"3","key":"12322_CR7","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1053\/gast.1997.v112.pm9041252","volume":"112","author":"F Wong","year":"1997","unstructured":"Wong F, Sniderman K, Liu P, Blendis L. The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology. 1997;112(3):899\u2013907.","journal-title":"Gastroenterology"},{"key":"12322_CR8","doi-asserted-by":"publisher","first-page":"l536","DOI":"10.1136\/bmj.l536","volume":"364","author":"AJ Stanley","year":"2019","unstructured":"Stanley AJ, Laine L. Management of acute upper gastrointestinal bleeding. BMJ. 2019;364:l536.","journal-title":"BMJ"},{"issue":"4","key":"12322_CR9","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3350\/cmh.2020.0022","volume":"26","author":"CRA Lesmana","year":"2020","unstructured":"Lesmana CRA, Raharjo M, Gani RA. Managing liver cirrhotic complications: overview of esophageal and gastric varices. Clin Mol Hepatol. 2020;26(4):444\u201360.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"12322_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.trre.2018.10.004","volume":"33","author":"CM Sellers","year":"2019","unstructured":"Sellers CM, Nezami N, Schilsky ML, Kim HS. Transjugular intrahepatic portosystemic shunt as a bridge to liver transplant: current state and future directions. Transplantation Reviews (Orlando Fla). 2019;33(2):64\u201371.","journal-title":"Transplantation Reviews (Orlando Fla)"},{"issue":"1","key":"12322_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12893-017-0243-9","volume":"17","author":"L Kong","year":"2017","unstructured":"Kong L, Li M, Li L, Jiang L, Yang J, Yan L. Splenectomy before adult liver transplantation: a retrospective study. BMC Surg. 2017;17(1):44.","journal-title":"BMC Surg"},{"issue":"3","key":"12322_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/j.sempedsurg.2012.05.005","volume":"21","author":"J de Ville","year":"2012","unstructured":"de Ville J, D\u2019Ambrosio G, Grimaldi C. Surgical management of portal hypertension in children. Semin Pediatr Surg. 2012;21(3):219\u201332.","journal-title":"Semin Pediatr Surg"},{"key":"12322_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-019-7307-7","author":"D-S Bai","year":"2019","unstructured":"Bai D-S, Zhou B-H, Qian J-J, Zhang C, Jin S-J, Jiang G-Q. Effects of laparoscopic splenectomy and azygoportal disconnection on liver synthesis function and cirrhosis: a 2-year prospective study. Surg Endosc. 2019. https:\/\/doi.org\/10.1007\/s00464-019-7307-7","journal-title":"Surg Endosc"},{"issue":"2","key":"12322_CR14","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jhep.2020.08.017","volume":"74","author":"T Yoshizumi","year":"2021","unstructured":"Yoshizumi T, Itoh S, Shimokawa M, Inokuchi S, Harada N, Takeishi K, et al. Simultaneous splenectomy improves outcomes after adult living donor liver transplantation. J Hepatol. 2021;74(2):372\u20139.","journal-title":"J Hepatol"},{"issue":"1","key":"12322_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jhep.2022.01.023","volume":"77","author":"AG Singal","year":"2022","unstructured":"Singal AG, Zhang E, Narasimman M, Rich NE, Waljee AK, Hoshida Y, et al. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis. J Hepatol. 2022;77(1):128\u201339.","journal-title":"J Hepatol"},{"issue":"5 Suppl 1","key":"12322_CR16","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","volume":"127","author":"G Fattovich","year":"2004","unstructured":"Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127(5 Suppl 1):S35\u201350.","journal-title":"Gastroenterology"},{"issue":"5","key":"12322_CR17","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jhep.2009.01.014","volume":"50","author":"C Ripoll","year":"2009","unstructured":"Ripoll C, Groszmann RJ, Garcia-Tsao G, Bosch J, Grace N, Burroughs A, et al. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol. 2009;50(5):923\u20138.","journal-title":"J Hepatol"},{"key":"12322_CR18","doi-asserted-by":"crossref","unstructured":"Kim R, Jeong WK, Kang TW, Song KD, Lee MW, Ahn SH et al. Intrahepatic distant recurrence after radiofrequency ablation of hepatocellular carcinoma: relationship with portal hypertension. Acta radiologica (Stockholm, Sweden: 1987). 2019;60(12):1609-18.","DOI":"10.1177\/0284185119842830"},{"issue":"3","key":"12322_CR19","first-page":"176","volume":"2","author":"A Mancuso","year":"2014","unstructured":"Mancuso A, Perricone G. Hepatocellular carcinoma and liver transplantation: state of the art. J Clin Translational Hepatol. 2014;2(3):176\u201381.","journal-title":"J Clin Translational Hepatol"},{"issue":"1","key":"12322_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1055\/a-2228-7496","volume":"62","author":"JP Gundlach","year":"2024","unstructured":"Gundlach JP, Ellrichmann M, van Rosmalen M, Vogelaar S, Eimer C, Rheinbay C, et al. Liver transplantation for HCC in cirrhosis: are Milan criteria outdated? Z Gastroenterol. 2024;62(1):43\u20139.","journal-title":"Z Gastroenterol"},{"issue":"1","key":"12322_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1053\/j.gastro.2017.09.025","volume":"154","author":"V Mazzaferro","year":"2018","unstructured":"Mazzaferro V, Sposito C, Zhou J, Pinna AD, De Carlis L, Fan J, et al. Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma. Gastroenterology. 2018;154(1):128\u201339.","journal-title":"Gastroenterology"},{"key":"12322_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijsu.2019.11.002","volume":"72","author":"R Agha","year":"2019","unstructured":"Agha R, Abdall-Razak A, Crossley E, Dowlut N, Iosifidis C, Mathew G. STROCSS 2019 guideline: strengthening the reporting of cohort studies in surgery. Int J Surg. 2019;72:156\u201365.","journal-title":"Int J Surg"},{"key":"12322_CR23","volume-title":"AJCC cancer staging manual","author":"MBGD Amin","year":"2017","unstructured":"Amin MBGD. AJCC cancer staging manual. 8th ed. New York, NY: Springer; 2017.","edition":"8"},{"issue":"4","key":"12322_CR24","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","volume":"62","author":"P Angeli","year":"2015","unstructured":"Angeli P, Gines P, Wong F, Bernardi M, Boyer TD, Gerbes A, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the international club of ascites. J Hepatol. 2015;62(4):968\u201374.","journal-title":"J Hepatol"},{"issue":"2","key":"12322_CR25","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc5713","volume":"11","author":"RL Mehta","year":"2007","unstructured":"Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.","journal-title":"Crit Care"},{"issue":"1","key":"12322_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Crit Care. 2013;17(1):204.","journal-title":"Crit Care"},{"issue":"9","key":"12322_CR27","first-page":"779","volume":"157","author":"P Tabrizian","year":"2022","unstructured":"Tabrizian P, Holzner ML, Mehta N, Halazun K, Agopian VG, Yao F, et al. Ten-year outcomes of liver transplant and downstaging for hepatocellular carcinoma. JAMA Surg. 2022;157(9):779\u201388.","journal-title":"JAMA Surg"},{"issue":"3","key":"12322_CR28","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jhep.2022.11.019","volume":"78","author":"D Thabut","year":"2023","unstructured":"Thabut D, Kudo M. Treatment of portal hypertension in patients with HCC in the era of Baveno VII. J Hepatol. 2023;78(3):658\u201362.","journal-title":"J Hepatol"},{"issue":"6","key":"12322_CR29","doi-asserted-by":"publisher","first-page":"e99167","DOI":"10.1371\/journal.pone.0099167","volume":"9","author":"KS Jung","year":"2014","unstructured":"Jung KS, Kim JH, Kim SU, Song K, Kim BK, Park JY, et al. Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma: development and validation of a predictive model. PLoS ONE. 2014;9(6):e99167\u2013e.","journal-title":"PLoS ONE"},{"issue":"2","key":"12322_CR30","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/hep.27431","volume":"61","author":"A Berzigotti","year":"2015","unstructured":"Berzigotti A, Reig M, Abraldes JG, Bosch J, Bruix J. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology (Baltimore MD). 2015;61(2):526\u201336.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"3","key":"12322_CR31","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s12072-022-10321-y","volume":"16","author":"Z Liu","year":"2022","unstructured":"Liu Z, Liu Y, Zhang W, Hong Y, Meng J, Wang J, et al. Deep learning for prediction of hepatocellular carcinoma recurrence after resection or liver transplantation: a discovery and validation study. Hepatol Int. 2022;16(3):577\u201389.","journal-title":"Hepatol Int"},{"issue":"5","key":"12322_CR32","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.jamcollsurg.2006.12.043","volume":"204","author":"J-N Vauthey","year":"2007","unstructured":"Vauthey J-N, Ribero D, Abdalla EK, Jonas S, Bharat A, Schumacher G, et al. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. J Am Coll Surg. 2007;204(5):1016\u201328.","journal-title":"J Am Coll Surg"},{"issue":"3","key":"12322_CR33","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/hep.20576","volume":"41","author":"R Ba\u00f1ares","year":"2005","unstructured":"Ba\u00f1ares R, N\u00fa\u00f1ez O, Escudero M, Fern\u00e1ndez C, Vaquero J, Beceiro I, et al. Patients with cirrhosis and bare-stent TIPS may have increased risk of hepatocellular carcinoma. Hepatology (Baltimore MD). 2005;41(3):566\u201371.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"1","key":"12322_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12876-023-03047-0","volume":"23","author":"A Fichtl","year":"2023","unstructured":"Fichtl A, Seufferlein T, Zizer E. Risks and benefits of TIPS in HCC and other liver malignancies: a literature review. BMC Gastroenterol. 2023;23(1):403.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"12322_CR35","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/01.RVI.0000064846.87207.AB","volume":"14","author":"M Wallace","year":"2003","unstructured":"Wallace M, Swaim M. Transjugular intrahepatic portosystemic shunts through hepatic neoplasms. J Vascular Interventional Radiology: JVIR. 2003;14(4):501\u20137.","journal-title":"J Vascular Interventional Radiology: JVIR"},{"issue":"1","key":"12322_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/apt.12994","volume":"41","author":"D Bettinger","year":"2015","unstructured":"Bettinger D, Kn\u00fcppel E, Euringer W, Spangenberg HC, R\u00f6ssle M, Thimme R, et al. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma. Aliment Pharmacol Ther. 2015;41(1):126\u201336.","journal-title":"Aliment Pharmacol Ther"},{"issue":"13","key":"12322_CR37","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.12998\/wjcc.v7.i13.1599","volume":"7","author":"S-H Luo","year":"2019","unstructured":"Luo S-H, Chu J-G, Huang H, Yao K-C. Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma. World J Clin Cases. 2019;7(13):1599\u2013610.","journal-title":"World J Clin Cases"},{"issue":"1","key":"12322_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/00365528509089633","volume":"20","author":"M Bj\u00f8rneboe","year":"1985","unstructured":"Bj\u00f8rneboe M, Andersen JR, Christensen U, Skinh\u00f8j P, Jensen OM. Does a portal-systemic shunt increase the risk of primary hepatic carcinoma in cirrhosis of the liver? Scand J Gastroenterol. 1985;20(1):59\u201364.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"12322_CR39","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/hep.20745","volume":"42","author":"L Libbrecht","year":"2005","unstructured":"Libbrecht L, Maleux G, Verslype C, Nevens F, Roskams T. Influence of TIPS on development of hepatocellular carcinoma in cirrhosis. Hepatology (Baltimore MD). 2005;42(1):236\u20137.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"3","key":"12322_CR40","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1053\/jhep.2003.50076","volume":"37","author":"D Cazals-Hatem","year":"2003","unstructured":"Cazals-Hatem D, Vilgrain V, Genin P, Denninger M-H, Durand F, Belghiti J, et al. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers. Hepatology (Baltimore MD). 2003;37(3):510\u20139.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"8","key":"12322_CR41","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.dld.2014.04.009","volume":"46","author":"A De Santis","year":"2014","unstructured":"De Santis A, Iegri C, Kondili L, Riggio O, Salvatori FM, Catalano C, et al. Hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt: a retrospective case-control study. Dig Liver Disease: Official J Italian Soc Gastroenterol Italian Association Study Liver. 2014;46(8):726\u201330.","journal-title":"Dig Liver Disease: Official J Italian Soc Gastroenterol Italian Association Study Liver"},{"issue":"1","key":"12322_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.dld.2014.09.009","volume":"47","author":"P Borentain","year":"2015","unstructured":"Borentain P, Garcia S, Gregoire E, Vidal V, Ananian P, Ressiot E, et al. Transjugular intrahepatic porto-systemic shunt is a risk factor for liver dysplasia but not hepatocellular carcinoma: a retrospective study of explanted livers. Dig Liver Disease: Official J Italian Soc Gastroenterol Italian Association Study Liver. 2015;47(1):57\u201361.","journal-title":"Dig Liver Disease: Official J Italian Soc Gastroenterol Italian Association Study Liver"},{"issue":"3","key":"12322_CR43","first-page":"232","volume":"7","author":"B Chen","year":"2019","unstructured":"Chen B, Pang L, Chen H-B, Wu D-B, Wang Y-H, Chen E-Q. TIPS is not associated with a higher risk of developing HCC in Cirrhotic patients: a systematic review and meta-analysis. J Clin Translational Hepatol. 2019;7(3):232\u20137.","journal-title":"J Clin Translational Hepatol"},{"issue":"2","key":"12322_CR44","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/hep.510260205","volume":"26","author":"T Tanaka","year":"1997","unstructured":"Tanaka T, Yamanaka N, Oriyama T, Furukawa K, Okamoto E. Factors regulating tumor pressure in hepatocellular carcinoma and implications for tumor spread. Hepatology. 1997;26(2):283\u20137.","journal-title":"Hepatology"},{"issue":"4","key":"12322_CR45","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/hep.27343","volume":"61","author":"M Fernandez","year":"2015","unstructured":"Fernandez M. Molecular pathophysiology of portal hypertension. Hepatology. 2015;61(4):1406\u201315.","journal-title":"Hepatology"},{"key":"12322_CR46","doi-asserted-by":"crossref","unstructured":"Allaire M, Rudler M, Thabut D. Portal hypertension and hepatocellular carcinoma: Des liaisons dangereuses?. Liver Int. 2021;41(8):1734\u201343.","DOI":"10.1111\/liv.14977"},{"issue":"1","key":"12322_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13046-016-0412-1","volume":"35","author":"L Kong","year":"2016","unstructured":"Kong L, Zhou Y, Bu H, Lv T, Shi Y, Yang J. Deletion of interleukin-6 in monocytes\/macrophages suppresses the initiation of hepatocellular carcinoma in mice. J Exp Clin Cancer Res. 2016;35(1):131.","journal-title":"J Exp Clin Cancer Res"},{"key":"12322_CR48","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.biopha.2017.01.107","volume":"88","author":"R Ma","year":"2017","unstructured":"Ma R, Chen J, Liang Y, Lin S, Zhu L, Liang X, et al. Sorafenib: a potential therapeutic drug for hepatic fibrosis and its outcomes. Biomed Pharmacother. 2017;88:459\u201368.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"12322_CR49","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.hbpd.2019.06.011","volume":"18","author":"N Kurata","year":"2019","unstructured":"Kurata N, Ogura Y, Ogiso S, Onishi Y, Kamei H, Kodera Y. Splenectomy in living donor liver transplantation and risk factors of portal vein thrombosis. Hepatobiliary Pancreat Dis Int. 2019;18(4):337\u201342.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"12322_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.surg.2020.02.017","volume":"168","author":"H Matsushima","year":"2020","unstructured":"Matsushima H, Fujiki M, Sasaki K, Cywinski JB, D\u2019Amico G, Uso TD, et al. Can pretransplant TIPS be harmful in liver transplantation? A propensity score matching analysis. Surgery. 2020;168(1):33\u20139.","journal-title":"Surgery"},{"issue":"8","key":"12322_CR51","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/00042737-200208000-00003","volume":"14","author":"D Tripathi","year":"2002","unstructured":"Tripathi D, Therapondos G, Redhead DN, Madhavan KK, Hayes PC. Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation. Eur J Gastroenterol Hepatol. 2002;14(8):827\u201332.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"12322_CR52","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.clinre.2013.09.003","volume":"38","author":"L Barbier","year":"2014","unstructured":"Barbier L, Hardwigsen J, Borentain P, Biance N, Daghfous A, Louis G, et al. Impact of transjugular intrahepatic portosystemic shunting on liver transplantation: 12-year single-center experience. Clin Res Hepatol Gastroenterol. 2014;38(2):155\u201363.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"9818","key":"12322_CR53","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/S0140-6736(11)61086-6","volume":"379","author":"J Huang","year":"2012","unstructured":"Huang J, Millis JM, Mao Y, Millis MA, Sang X, Zhong S. A pilot programme of organ donation after cardiac death in China. Lancet. 2012;379(9818):862\u20135.","journal-title":"Lancet"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12322-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12322-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12322-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T15:04:55Z","timestamp":1714748695000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12322-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12322"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12322-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,3]]},"assertion":[{"value":"25 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In our study, the liver grafts utilized for LT since 2007 were obtained from deceased citizens in accordance with a new organ procurement and allocation policy implemented in China after 2012 ([]). No prisoners were included as donors. The protocol was approved by the Ethics Committee of the West China Hospital of Sichuan University West China Hospital. Written informed consent was obtained from all the recipients prior to their surgery, and all of donations were voluntary and altruistic in all cases, and were in accordance with the ethical guidelines of the Declaration of Helsinki. The written informed consents from the next of kin of the dead citizen are kept at the Red Cross Society of Sichuan Province, China. ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and source of grafts"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"558"}}